Therapeutics Delivery for Neurodegenerative Diseases (R21)
Funding Contact(s): Diane DiEuliis, Ph.D.
Funding Categories: Neurodegeneration
Brief Description:
This funding opportunity will utilize the Exploratory/Developmental (R21) to solicit grant applications from applicant organizations
that propose to develop biomarkers of neurodegenerative disease.